Insurance Giant Humana Stock Tumbles 9% After Q2 Earnings Beat, Issues Sub Par Profit Outlook
Insurance Giant Humana Stock Tumbles 9% After Q2 Earnings Beat, Issues Sub Par Profit Outlook
Wednesday,$Humana (HUM.US)$ posted second-quarter adjusted EPS of $6.96, down from $8.94 a year ago, beating the consensus of $5.85.
星期三，$哈門那 (HUM.US)$ 第二季度每股收益爲$6.96，低於去年的$8.94，超過預期的$5.85。
"This outperformance was driven by higher than anticipated revenue in our MA business, combined with favorable claims development and lower than planned administrative expenses, some of which is considered timing in nature," the company said.
公司表示：“這一業績優於預期，主要是因爲醫療保險業務的收入高於預期，加上有利的索賠處理和計劃內的較低行政費用，其中一部分被認爲是計時性質。”
The company reported revenues of $29.54 billion, up from $26.75 billion, beating the consensus of $28.51 billion.
公司報告的營業收入爲$295.4億，高於267.5億，超過預期的285.1億。
The sales increased on higher per-member Medicare premiums, and Medicare Advantage and state-based contracts membership growth.
銷售額增加主要是由於每位醫保成員的保費增加，以及醫療保險業務和州級協議的成員增長。
"Revenue for the quarter was slightly favorable to expectations driven by the higher than anticipated membership growth, along with slightly higher than anticipated member risk scores," Humana's management team said in prepared remarks.
哈門那的管理團隊在準備好的聲明中表示：“本季度的營收略高於預期，主要是由於預期之外的會員增長，以及略高於預期的會員風險評分。”
Humana ended the second quarter with 16.3 million in total medical membership, down from 17.13 million a year ago. Medicare Advantage membership reached 5.62 million, up from 5.27 million a year ago.
截至第二季度末，哈門那總的醫療保險成員數爲1630萬，低於去年的1713萬。醫療保險業務則有562萬成員，高於去年的527萬。
The benefit ratio increased to 89.0% from 86.3% a year ago, positively impacted by favorable claims development and slightly higher than anticipated member risk scores. This favorability was partially offset by higher MA net inpatient costs.
受有利的索賠處理和略高於預期的會員風險評分影響，利潤比率從去年的86.3%上升至89.0%。這一利好情況被較高的醫療保險住院治療淨費用所部分抵消。
Humana experienced favorable claims development in the quarter, primarily due to lower inpatient unit costs, observation stays, and higher claim recoveries.
本季度哈門那的索賠處理情況較爲有利，主要是由於住院單位成本減少、觀察逗留時間減少以及索賠收回增加。
This favorability was partially offset by higher-than-anticipated inpatient admissions, which increased above expectations in the back half of the quarter.
然而，本季度住院次數高於預期，上半季度比預期更高。
Humana raised its 2024 individual Medicare Advantage annual membership growth expectations by 75,000 to a new target of 225,000.
哈門那將其2024年個人醫保年度成員增長預期上調75,000，達到新目標225,000。
The company reaffirms 2024 adjusted EPS of ~$16.00 versus the consensus of $20.31. Humana expects a 2024 insurance segment benefit ratio of approximately 90%.
公司重申2024年每股收益目標爲~$16.00，預測值爲$20.31。哈門那預計2024年保險業務利潤率爲約90%。
"Looking ahead to 2025, we are focused on driving growth and further productivity across the enterprise to support sustainable earnings growth," Humana said.
哈門那表示：“展望2025年，我們專注於推動企業增長和提高生產率，支持可持續盈利增長。”